Cited by — A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite A phase 1 study of interleukin-15 in combination with mogamulizumab in relapsed and refractory T-cell malignancies.
No admitted local citation edges point to this work yet.
